Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 11Recruiting 5Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 2

Conditions

Neoplasms 13Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 5Prostatic Neoplasms 4Neoplasm Metastasis 3Melanoma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Multiple Myeloma 2Lung Neoplasms 2Liver Neoplasms 2Glioblastoma 2Fibrosis 2Colorectal Neoplasms 2Cachexia 2Vascular Malformations 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Renal Insufficiency, Chronic 1Recurrence 1Pneumonia 1Ovarian Neoplasms 1Ovarian Cysts 1Osteosarcoma 1Obesity 1

Interventions

Dexamethasone 112Bortezomib 61Lenalidomide 49Cyclophosphamide 49Calcium Dobesilate 43pomalidomide 32Melphalan 31fludarabine 25Filgrastim 25carfilzomib 22fludarabine phosphate 21daratumumab 20Granulocyte Colony-Stimulating Factor 16Whole-Body Irradiation 15Antilymphocyte Serum 15dexamethasone acetate 14Mycophenolic Acid 14Thalidomide 13Tacrolimus 13Cyclosporine 13Busulfan 13Peripheral Blood Stem Cell Transplantation 12ixazomib 11dexamethasone 21-phosphate 10auricularum 10pembrolizumab 9Radiotherapy 9Etoposide 9belantamab mafodotin 8Rituximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Multiple Myeloma × Blood Specimen Collection × Clear all
NCT04111809 2025-09-25

AMBROBiMM

Assistance Publique - Hôpitaux de Paris

Terminated
3 enrolled
Plasma cell

Multiple Myeloma

NCT03804424 2024-11-12

64Cu-LLP2A for Imaging Multiple Myeloma

Washington University School of Medicine

Phase EARLY_PHASE1 Terminated
10 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡